Just 1 in 3 Alzheimer patients know their diagnosis

Alzheimer; News from the web:

A pretty alarming statistic, apparently only 45% of patients and caregivers are told the diagnosis of alzheimer and if you only count the patients themselves the number drops to 33%. Doctors tend to not tell the diagnosis to avoid emotional stress. Read the report by the Alzheimer association for more details….. and talk to your doctor about this.

Read all about it HERE

Diets that will lower your risk of getting alzheimer

Alzheimer; News from the web:

The scientists at Rush University have developed a diet that can reduce your risk of contracting alzheimer by 53%. Two other diets have also shown to be effective.

Read all about it HERE and more HERE

from the press release:

The MIND diet has 15 dietary components, including 10 “brain-healthy food groups” — green leafy vegetables, other vegetables, nuts, berries, beans, whole grains, fish, poultry, olive oil and wine — and five unhealthy groups that comprise red meats, butter and stick margarine, cheese, pastries and sweets, and fried or fast food.

With the MIND diet, a person who eats at least three servings of whole grains, a salad and one other vegetable every day — along with a glass of wine — snacks most days on nuts, has beans every other day or so, eats poultry and berries at least twice a week and fish at least once a week and benefit. However, he or she must limits intake of the designated unhealthy foods, especially butter (less than 1 tablespoon a day), cheese, and fried or fast food (less than a serving a week for any of the three), to have a real shot at avoiding the devastating effects of AD, according to the study.

Berries are the only fruit specifically to make the MIND diet. “Blueberries are one of the more potent foods in terms of protecting the brain,” Morris said, and strawberries have also performed well in past studies of the effect of food on cognitive function.

Great News, another drug seems to work to fight alzheimer!

Alzheimer; News from the web:

An experimental drug for Alzheimer’s disease sharply slowed the decline in mental function in a small clinical trial, researchers reported Friday, reviving hopes for an approach to therapy that until now has experienced repeated failures.

The drug, being developed by Biogen Idec, could achieve sales of billions of dollars a year if the results from the small trial are replicated in larger trials that Biogen said it hoped to begin this year. Experts say that there are no really good drugs now to treat Alzheimer’s.

Read all about it HERE